Treatment of Acute CPP Crystal Arthritis When One or Two Joints Are Affected

When acute CPP crystal arthritis is limited to one or two joints, a focused, joint-directed management strategy is recommended. This protocol outlines the clinical approach and the goals expected from treatment.

Clinical Scenario

The patient presents with acute CPP crystal arthritis localised to one or two affected joints — a presentation that is well-suited to targeted, local intervention rather than systemic therapy.

Treatment Approach

The recommended approach centres on a local joint procedure combined with an intraarticular glucocorticoid injection, with the specific preparation varying by joint size.

The complete regimen — specific agents, dosing, and stepwise approach — is available in the full protocol below.

Treatment Goals

The primary aim is resolution of the acute flare: pain and swelling are expected to subside within 8–24 hours following appropriate joint-directed treatment.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.3389/fmed.2024.1327715

For patients with acute CPP arthritis that affects one or two joints, joint aspiration and intraarticular glucocorticoid injection are suggested.
For large joints like knees and shoulders, triamcinolone acetonide (40–80 mg) mixed with 1 or 2 mL of lidocaine can be used, while smaller doses of glucocorticoid preparations can be used for smaller joints.
After injection, pain and swelling usually subside within 8–24 h.

View source ↗